• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CHM

CHIMERIC THERAPEUTICS LIMITED - Announcements

25.0% ! 0.3¢
Market Cap $9.747M  !

Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company,... Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company, focused on the discovery, development, and commercialization of cell therapies for patients with cancer. Its diversified portfolio includes first-in-class autologous CAR T cell therapies and allogeneic natural killer (NK) cell therapies. Its assets are being developed across multiple different disease areas in oncology with four clinical stage programs. Its pipeline includes CHM CDH17, CHM CLTX and CHM CORE NK platform. CHM CDH17 is a third-generation CDH17 CAR T, which is in phase I/II clinical trial in gastrointestinal and neuroendocrine tumors. CHM CORE-NK is a clinically validated NK cell platform in phase IB clinical trials investigating CORE-NK in combination regimens. CHM CLTX is a novel CAR-T therapy developed for the treatment of patients with solid tumors. CLTX CAR T is in phase IB clinical trial in recurrent/progressive glioblastoma. It is also building a Cell therapy portfolio.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements



CHM Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/10/23 download Created with Sketch. 887.35KB
CHM FDA clearance of IND for CHM 2101PRICE SENSITIVE31/10/23 download Created with Sketch. 197.28KB
CHM Entitlement Offer update to timetable25/10/23 download Created with Sketch. 208.91KB
CHM Entitlement Offer cleansing notice under section 708AA25/10/23 download Created with Sketch. 233.51KB
CHM Proposed issue of securities - CHM25/10/23 download Created with Sketch. 24.47KB
CHM Investor Presentation - Entitlement Offer25/10/23 download Created with Sketch. 2.96MB
CHM Proposed issue of securities - CHM25/10/23 download Created with Sketch. 28.61KB
CHM Entitlement Offer to raise approximately $10 millionPRICE SENSITIVE25/10/23 download Created with Sketch. 254.68KB
CHM New data for Phase 1A CLTX CAR T brain cancer clinical trialPRICE SENSITIVE23/10/23 download Created with Sketch. 424.1KB
CHM Trading HaltPRICE SENSITIVE20/10/23 download Created with Sketch. 568.27KB
CHM Notice of Annual General Meeting/Proxy Form16/10/23 download Created with Sketch. 660.58KB
CHM Notice under section 708A04/10/23 download Created with Sketch. 222.5KB
CHM Application for quotation of securities - CHM04/10/23 download Created with Sketch. 24.99KB
CHM ESG Report28/09/23 download Created with Sketch. 369.58KB
CHM Appendix 4G28/09/23 download Created with Sketch. 267.62KB
CHM Corporate Governance Statement28/09/23 download Created with Sketch. 164.18KB
CHM Annual Report to shareholders28/09/23 download Created with Sketch. 2.09MB
CHM Notification regarding unquoted securities - CHM19/09/23 download Created with Sketch. 23.66KB
CHM Results of Extraordinary General Meeting13/09/23 download Created with Sketch. 213.71KB
CHM EGM Presentation13/09/23 download Created with Sketch. 1.57MB
CHM Agreement with MD Anderson for Phase 1B CHM 0201 AML studyPRICE SENSITIVE13/09/23 download Created with Sketch. 277.45KB
CHM Appendix 4E and Preliminary Final ReportPRICE SENSITIVE31/08/23 download Created with Sketch. 1.06MB
CHM Final Director's Interest Notice CE31/08/23 download Created with Sketch. 231.55KB
CHM Initial Director's Interest Notice ES31/08/23 download Created with Sketch. 201.19KB
CHM Non-Executive Director Board Changes30/08/23 download Created with Sketch. 172.91KB
CHM Dosing completion in Phase 1A brain cancer clinical trialPRICE SENSITIVE29/08/23 download Created with Sketch. 197.16KB
CHM Late lodgement of Appendix 3Y28/08/23 download Created with Sketch. 360.22KB
CHM Chimeric to receive A$4.4 million introduction feePRICE SENSITIVE16/08/23 download Created with Sketch. 170.91KB
CHM Positive data - CHM 0301 next-gen armoured NK cell platformPRICE SENSITIVE15/08/23 download Created with Sketch. 270.01KB
CHM Notice of Extraordinary General Meeting/Proxy Form15/08/23 download Created with Sketch. 832.88KB
CHM Final Director's Interest Notice03/08/23 download Created with Sketch. 218.87KB
CHM Resignation of Director03/08/23 download Created with Sketch. 169.92KB
CHM Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/07/23 download Created with Sketch. 1.24MB
CHM Patent allowance for Chlorotoxin in Japan27/07/23 download Created with Sketch. 170.84KB
CHM Change in substantial holding PH17/07/23 download Created with Sketch. 269.99KB
CHM Final Director's Interest Notice LC17/07/23 download Created with Sketch. 214.02KB
CHM Initial Director's Interest Notice PH17/07/23 download Created with Sketch. 175.02KB
CHM Change of Director's Interest Notice x 617/07/23 download Created with Sketch. 333.96KB
CHM Notice under section 708A14/07/23 download Created with Sketch. 221.12KB
CHM Notification regarding unquoted securities - CHM14/07/23 download Created with Sketch. 25.97KB
CHM Application for quotation of securities - CHM14/07/23 download Created with Sketch. 24.69KB
CHM Board Changes Director12/07/23 download Created with Sketch. 113.34KB
CHM Notice under section 708A29/06/23 download Created with Sketch. 221.72KB
CHM Application for quotation of securities - CHM29/06/23 download Created with Sketch. 24.98KB
CHM Results of Extraordinary General Meeting29/06/23 download Created with Sketch. 204.19KB
CHM Application for quotation of securities - CHM23/06/23 download Created with Sketch. 25.58KB
CHM Proposed issue of securities - CHM23/06/23 download Created with Sketch. 26.65KB
CHM Proposed issue of securities - CHM23/06/23 download Created with Sketch. 24.94KB
CHM CHM secures up to A$12.6m through SPP and placementsPRICE SENSITIVE23/06/23 download Created with Sketch. 283.69KB
CHM Application for quotation of securities - CHM23/06/23 download Created with Sketch. 24.68KB
CHM Share purchase plan completedPRICE SENSITIVE23/06/23 download Created with Sketch. 157.22KB
CHM Chimeric's Phase 1B glioblastoma trial presented at ASCO2306/06/23 download Created with Sketch. 950.08KB
CHM Launch of new Phase 1B Glioblastoma clinical trialPRICE SENSITIVE05/06/23 download Created with Sketch. 211.21KB
CHM Update - Proposed issue of securities - CHM02/06/23 download Created with Sketch. 28.72KB
CHM Share purchase plan (SPP) - closing date extended02/06/23 download Created with Sketch. 160.62KB
CHM Notice of Extraordinary General Meeting/Proxy Form31/05/23 download Created with Sketch. 473.25KB
CHM SPP offer documents issued to shareholdersPRICE SENSITIVE23/05/23 download Created with Sketch. 576.49KB
CHM SPP Cleansing Notice23/05/23 download Created with Sketch. 200.24KB
CHM Proposed issue of securities - CHM15/05/23 download Created with Sketch. 28.97KB
CHM Proposed issue of securities - CHM15/05/23 download Created with Sketch. 24.63KB
CHM BOARD & MANAGEMENT COMMIT TO $1M PLACEMENT AND PROPOSED SPPPRICE SENSITIVE15/05/23 download Created with Sketch. 210.66KB
CHM Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE28/04/23 download Created with Sketch. 1.12MB
CHM New CLTX CAR technology patent protection in India & IsraelPRICE SENSITIVE28/04/23 download Created with Sketch. 193.29KB
CHM Phase 1B brain cancer clinical trial approved for initiationPRICE SENSITIVE26/04/23 download Created with Sketch. 308.11KB
CHM CHM to host CAR T Cell Therapies Educational Webinar11/04/23 download Created with Sketch. 190.98KB
CHM CHM 1101 GBM Abstract Accepted for ASCO 2023 PresentationPRICE SENSITIVE03/04/23 download Created with Sketch. 236.95KB
CHM Positive pre-IND meeting with FDA for Phase 1 CAR T studyPRICE SENSITIVE21/03/23 download Created with Sketch. 193.17KB
CHM Chimeric to present at virtual healthcare conference15/03/23 download Created with Sketch. 168.81KB
CHM Completion of Viral Vector Manufacturing for Phase 1 trial09/03/23 download Created with Sketch. 192.73KB
CHM Fourth dose cohort initiated in CHM 1101 Phase 1 trialPRICE SENSITIVE02/03/23 download Created with Sketch. 195.33KB
CHM Appendix 4D and Half Year ReportPRICE SENSITIVE28/02/23 download Created with Sketch. 1.66MB
CHM CHIMERIC RECEIVES $3.06M R&D TAX INCENTIVEPRICE SENSITIVE14/02/23 download Created with Sketch. 169.65KB
CHM Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/01/23 download Created with Sketch. 1.29MB
CHM Follow up period completed for 3rd cohort in CHM 1101 trialPRICE SENSITIVE23/01/23 download Created with Sketch. 193.95KB
CHM 1st patient dosed in CHM 0201 Vactosertib trial19/01/23 download Created with Sketch. 216.25KB
CHM Application for quotation of securities - CHM18/01/23 download Created with Sketch. 24.38KB
CHM Release of Securities from Escrow10/01/23 download Created with Sketch. 129.7KB
CHM Notice under section 708A22/12/22 download Created with Sketch. 99.56KB
CHM Application for quotation of securities - CHM22/12/22 download Created with Sketch. 26.46KB
CHM Dosing complete in 3rd cohort of CHM 1101 (CLTX CAR T) trialPRICE SENSITIVE22/12/22 download Created with Sketch. 194.91KB
CHM Change of Director's Interest Notice - JC15/12/22 download Created with Sketch. 207.24KB
CHM Application for quotation of securities - CHM13/12/22 download Created with Sketch. 25.72KB
CHM Change of Director's Interest Notice - JC24/11/22 download Created with Sketch. 210.98KB
CHM License agreement with CWRU - supplementary announcement24/11/22 download Created with Sketch. 172.74KB
CHM Exclusive license agreement with CWRU for CORE-NK platformPRICE SENSITIVE21/11/22 download Created with Sketch. 199.94KB
CHM Notification regarding unquoted securities - CHM18/11/22 download Created with Sketch. 33.82KB
CHM Notice under section 708A18/11/22 download Created with Sketch. 100.07KB
CHM Application for quotation of securities - CHM18/11/22 download Created with Sketch. 43.26KB
CHM Results of Meeting15/11/22 download Created with Sketch. 150.94KB
CHM AGM Presentation15/11/22 download Created with Sketch. 10.49MB
CHM AGM ATTENDANCE08/11/22 download Created with Sketch. 161.13KB
CHM Sponsored Research Agreement to advance CORE-NK portfolio02/11/22 download Created with Sketch. 197.84KB
CHM Change of Registry Address31/10/22 download Created with Sketch. 77.61KB
CHM Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE28/10/22 download Created with Sketch. 1.14MB
CHM Notice of Annual General Meeting/Proxy Form14/10/22 download Created with Sketch. 1.11MB
CHM ESG Report30/09/22 download Created with Sketch. 2.12MB
CHM Appendix 4G30/09/22 download Created with Sketch. 256.48KB
CHM Annual Report to shareholders30/09/22 download Created with Sketch. 2.01MB
CHM Corporate Governance Statement30/09/22 download Created with Sketch. 185.31KB
CHM Notification regarding unquoted securities - CHM28/09/22 download Created with Sketch. 47.03KB
CHM Quarterly Activities/Appendix 4C Cash Flow Report
31/10/23PRICE SENSITIVE download Created with Sketch. 887.35KB
CHM FDA clearance of IND for CHM 2101
31/10/23PRICE SENSITIVE download Created with Sketch. 197.28KB
CHM Entitlement Offer update to timetable
25/10/23 download Created with Sketch. 208.91KB
CHM Entitlement Offer cleansing notice under section 708AA
25/10/23 download Created with Sketch. 233.51KB
CHM Proposed issue of securities - CHM
25/10/23 download Created with Sketch. 24.47KB
CHM Investor Presentation - Entitlement Offer
25/10/23 download Created with Sketch. 2.96MB
CHM Proposed issue of securities - CHM
25/10/23 download Created with Sketch. 28.61KB
CHM Entitlement Offer to raise approximately $10 million
25/10/23PRICE SENSITIVE download Created with Sketch. 254.68KB
CHM New data for Phase 1A CLTX CAR T brain cancer clinical trial
23/10/23PRICE SENSITIVE download Created with Sketch. 424.1KB
CHM Trading Halt
20/10/23PRICE SENSITIVE download Created with Sketch. 568.27KB
CHM Notice of Annual General Meeting/Proxy Form
16/10/23 download Created with Sketch. 660.58KB
CHM Notice under section 708A
04/10/23 download Created with Sketch. 222.5KB
CHM Application for quotation of securities - CHM
04/10/23 download Created with Sketch. 24.99KB
CHM ESG Report
28/09/23 download Created with Sketch. 369.58KB
CHM Appendix 4G
28/09/23 download Created with Sketch. 267.62KB
CHM Corporate Governance Statement
28/09/23 download Created with Sketch. 164.18KB
CHM Annual Report to shareholders
28/09/23 download Created with Sketch. 2.09MB
CHM Notification regarding unquoted securities - CHM
19/09/23 download Created with Sketch. 23.66KB
CHM Results of Extraordinary General Meeting
13/09/23 download Created with Sketch. 213.71KB
CHM EGM Presentation
13/09/23 download Created with Sketch. 1.57MB
CHM Agreement with MD Anderson for Phase 1B CHM 0201 AML study
13/09/23PRICE SENSITIVE download Created with Sketch. 277.45KB
CHM Appendix 4E and Preliminary Final Report
31/08/23PRICE SENSITIVE download Created with Sketch. 1.06MB
CHM Final Director's Interest Notice CE
31/08/23 download Created with Sketch. 231.55KB
CHM Initial Director's Interest Notice ES
31/08/23 download Created with Sketch. 201.19KB
CHM Non-Executive Director Board Changes
30/08/23 download Created with Sketch. 172.91KB
CHM Dosing completion in Phase 1A brain cancer clinical trial
29/08/23PRICE SENSITIVE download Created with Sketch. 197.16KB
CHM Late lodgement of Appendix 3Y
28/08/23 download Created with Sketch. 360.22KB
CHM Chimeric to receive A$4.4 million introduction fee
16/08/23PRICE SENSITIVE download Created with Sketch. 170.91KB
CHM Positive data - CHM 0301 next-gen armoured NK cell platform
15/08/23PRICE SENSITIVE download Created with Sketch. 270.01KB
CHM Notice of Extraordinary General Meeting/Proxy Form
15/08/23 download Created with Sketch. 832.88KB
CHM Final Director's Interest Notice
03/08/23 download Created with Sketch. 218.87KB
CHM Resignation of Director
03/08/23 download Created with Sketch. 169.92KB
CHM Quarterly Activities/Appendix 4C Cash Flow Report
31/07/23PRICE SENSITIVE download Created with Sketch. 1.24MB
CHM Patent allowance for Chlorotoxin in Japan
27/07/23 download Created with Sketch. 170.84KB
CHM Change in substantial holding PH
17/07/23 download Created with Sketch. 269.99KB
CHM Final Director's Interest Notice LC
17/07/23 download Created with Sketch. 214.02KB
CHM Initial Director's Interest Notice PH
17/07/23 download Created with Sketch. 175.02KB
CHM Change of Director's Interest Notice x 6
17/07/23 download Created with Sketch. 333.96KB
CHM Notice under section 708A
14/07/23 download Created with Sketch. 221.12KB
CHM Notification regarding unquoted securities - CHM
14/07/23 download Created with Sketch. 25.97KB
CHM Application for quotation of securities - CHM
14/07/23 download Created with Sketch. 24.69KB
CHM Board Changes Director
12/07/23 download Created with Sketch. 113.34KB
CHM Notice under section 708A
29/06/23 download Created with Sketch. 221.72KB
CHM Application for quotation of securities - CHM
29/06/23 download Created with Sketch. 24.98KB
CHM Results of Extraordinary General Meeting
29/06/23 download Created with Sketch. 204.19KB
CHM Application for quotation of securities - CHM
23/06/23 download Created with Sketch. 25.58KB
CHM Proposed issue of securities - CHM
23/06/23 download Created with Sketch. 26.65KB
CHM Proposed issue of securities - CHM
23/06/23 download Created with Sketch. 24.94KB
CHM CHM secures up to A$12.6m through SPP and placements
23/06/23PRICE SENSITIVE download Created with Sketch. 283.69KB
CHM Application for quotation of securities - CHM
23/06/23 download Created with Sketch. 24.68KB
CHM Share purchase plan completed
23/06/23PRICE SENSITIVE download Created with Sketch. 157.22KB
CHM Chimeric's Phase 1B glioblastoma trial presented at ASCO23
06/06/23 download Created with Sketch. 950.08KB
CHM Launch of new Phase 1B Glioblastoma clinical trial
05/06/23PRICE SENSITIVE download Created with Sketch. 211.21KB
CHM Update - Proposed issue of securities - CHM
02/06/23 download Created with Sketch. 28.72KB
CHM Share purchase plan (SPP) - closing date extended
02/06/23 download Created with Sketch. 160.62KB
CHM Notice of Extraordinary General Meeting/Proxy Form
31/05/23 download Created with Sketch. 473.25KB
CHM SPP offer documents issued to shareholders
23/05/23PRICE SENSITIVE download Created with Sketch. 576.49KB
CHM SPP Cleansing Notice
23/05/23 download Created with Sketch. 200.24KB
CHM Proposed issue of securities - CHM
15/05/23 download Created with Sketch. 28.97KB
CHM Proposed issue of securities - CHM
15/05/23 download Created with Sketch. 24.63KB
CHM BOARD & MANAGEMENT COMMIT TO $1M PLACEMENT AND PROPOSED SPP
15/05/23PRICE SENSITIVE download Created with Sketch. 210.66KB
CHM Quarterly Activities/Appendix 4C Cash Flow Report
28/04/23PRICE SENSITIVE download Created with Sketch. 1.12MB
CHM New CLTX CAR technology patent protection in India & Israel
28/04/23PRICE SENSITIVE download Created with Sketch. 193.29KB
CHM Phase 1B brain cancer clinical trial approved for initiation
26/04/23PRICE SENSITIVE download Created with Sketch. 308.11KB
CHM CHM to host CAR T Cell Therapies Educational Webinar
11/04/23 download Created with Sketch. 190.98KB
CHM CHM 1101 GBM Abstract Accepted for ASCO 2023 Presentation
03/04/23PRICE SENSITIVE download Created with Sketch. 236.95KB
CHM Positive pre-IND meeting with FDA for Phase 1 CAR T study
21/03/23PRICE SENSITIVE download Created with Sketch. 193.17KB
CHM Chimeric to present at virtual healthcare conference
15/03/23 download Created with Sketch. 168.81KB
CHM Completion of Viral Vector Manufacturing for Phase 1 trial
09/03/23 download Created with Sketch. 192.73KB
CHM Fourth dose cohort initiated in CHM 1101 Phase 1 trial
02/03/23PRICE SENSITIVE download Created with Sketch. 195.33KB
CHM Appendix 4D and Half Year Report
28/02/23PRICE SENSITIVE download Created with Sketch. 1.66MB
CHM CHIMERIC RECEIVES $3.06M R&D TAX INCENTIVE
14/02/23PRICE SENSITIVE download Created with Sketch. 169.65KB
CHM Quarterly Activities/Appendix 4C Cash Flow Report
31/01/23PRICE SENSITIVE download Created with Sketch. 1.29MB
CHM Follow up period completed for 3rd cohort in CHM 1101 trial
23/01/23PRICE SENSITIVE download Created with Sketch. 193.95KB
CHM 1st patient dosed in CHM 0201 Vactosertib trial
19/01/23 download Created with Sketch. 216.25KB
CHM Application for quotation of securities - CHM
18/01/23 download Created with Sketch. 24.38KB
CHM Release of Securities from Escrow
10/01/23 download Created with Sketch. 129.7KB
CHM Notice under section 708A
22/12/22 download Created with Sketch. 99.56KB
CHM Application for quotation of securities - CHM
22/12/22 download Created with Sketch. 26.46KB
CHM Dosing complete in 3rd cohort of CHM 1101 (CLTX CAR T) trial
22/12/22PRICE SENSITIVE download Created with Sketch. 194.91KB
CHM Change of Director's Interest Notice - JC
15/12/22 download Created with Sketch. 207.24KB
CHM Application for quotation of securities - CHM
13/12/22 download Created with Sketch. 25.72KB
CHM Change of Director's Interest Notice - JC
24/11/22 download Created with Sketch. 210.98KB
CHM License agreement with CWRU - supplementary announcement
24/11/22 download Created with Sketch. 172.74KB
CHM Exclusive license agreement with CWRU for CORE-NK platform
21/11/22PRICE SENSITIVE download Created with Sketch. 199.94KB
CHM Notification regarding unquoted securities - CHM
18/11/22 download Created with Sketch. 33.82KB
CHM Notice under section 708A
18/11/22 download Created with Sketch. 100.07KB
CHM Application for quotation of securities - CHM
18/11/22 download Created with Sketch. 43.26KB
CHM Results of Meeting
15/11/22 download Created with Sketch. 150.94KB
CHM AGM Presentation
15/11/22 download Created with Sketch. 10.49MB
CHM AGM ATTENDANCE
08/11/22 download Created with Sketch. 161.13KB
CHM Sponsored Research Agreement to advance CORE-NK portfolio
02/11/22 download Created with Sketch. 197.84KB
CHM Change of Registry Address
31/10/22 download Created with Sketch. 77.61KB
CHM Quarterly Activities/Appendix 4C Cash Flow Report
28/10/22PRICE SENSITIVE download Created with Sketch. 1.14MB
CHM Notice of Annual General Meeting/Proxy Form
14/10/22 download Created with Sketch. 1.11MB
CHM ESG Report
30/09/22 download Created with Sketch. 2.12MB
CHM Appendix 4G
30/09/22 download Created with Sketch. 256.48KB
CHM Annual Report to shareholders
30/09/22 download Created with Sketch. 2.01MB
CHM Corporate Governance Statement
30/09/22 download Created with Sketch. 185.31KB
CHM Notification regarding unquoted securities - CHM
28/09/22 download Created with Sketch. 47.03KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
0.3¢
Change
-0.001(25.0%)
Mkt cap ! $9.747M
Open High Low Value Volume
0.3¢ 0.4¢ 0.3¢ $11.33K 3.775M

Buyers (Bids)

No. Vol. Price($)
75 71644408 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 87927011 26
View Market Depth
Last trade - 14.48pm 31/07/2025 (20 minute delay) ?
Last
0.4¢
  Change
-0.001 ( 16.7 %)
Open High Low Volume
0.4¢ 0.4¢ 0.3¢ 568204
Last updated 12.29pm 31/07/2025 ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.